NCT03620786 2026-04-16
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
University of California, Los Angeles
Recruiting
Clinical Trials
744 trialsNCT05497024 2026-04-16
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
M.D. Anderson Cancer Center
Recruiting
NCT06171139 2026-04-16
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
University of California, San Francisco
Phase NA Recruiting
NCT06347705 2026-04-16
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04693377 2026-04-15
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT05424783 2026-04-15
MAGIC
Northwestern University
Recruiting
NCT06615752 2026-04-15
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Charles Drew University of Medicine and Science
Phase 1/2 Recruiting
NCT07002320 2026-04-15
ASpiRE
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
NCT07111507 2026-04-15
A Study of Tarlatamab for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07237269 2026-04-15
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
University of Nebraska
Phase 2 Recruiting
NCT07531329 2026-04-15
DEPICT
Xijing Hospital
Recruiting
NCT05487846 2026-04-14
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Thomas Jefferson University
Phase NA Recruiting
NCT04337580 2026-04-13
FASN
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT05113537 2026-04-13
UPLIFT
University of California, San Francisco
Phase 1/2 Recruiting
NCT05313191 2026-04-13
ReRT
The New York Proton Center
Phase NA Recruiting
NCT05558241 2026-04-13
MUSIC-AS
University of Alberta
Phase NA Recruiting
NCT06594926 2026-04-13
WOMBAT
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Recruiting
NCT06616155 2026-04-13
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Recruiting
NCT07093177 2026-04-13
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
University of Utah
Phase NA Recruiting
NCT07220720 2026-04-13
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
University of Florida
Phase 2 Recruiting
NCT00588185 2026-04-09
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT05710861 2026-04-09
EMERHIT
University Hospital, Bordeaux
Phase NA Recruiting
NCT07520916 2026-04-09
MPE-RP
Giresun University
Phase NA Recruiting
NCT02706561 2026-04-08
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT05469269 2026-04-08
Cleveland African American Prostate Cancer Project
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT05478694 2026-04-08
Outcomes of Focal Ablation for Prostate Cancer
University of Texas Southwestern Medical Center
Recruiting
NCT07463092 2026-04-08
Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy
University of Sao Paulo
Phase NA Recruiting
NCT07516886 2026-04-08
PPSARP
Lithuanian University of Health Sciences
Recruiting
NCT05334069 2026-04-07
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Recruiting
NCT06039085 2026-04-07
RARP EI
Dartmouth-Hitchcock Medical Center
Recruiting
NCT06632977 2026-04-07
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT06931340 2026-04-07
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT03880422 2026-04-06
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06389786 2026-04-06
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT05946213 2026-04-03
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NRG Oncology
Phase 3 Recruiting
NCT06085729 2026-04-02
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT07365423 2026-04-02
TerbinaPro
Swiss Cancer Institute
Phase 2 Recruiting
NCT06651359 2026-04-01
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
University of Oklahoma
Phase NA Recruiting
NCT06954337 2026-04-01
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07054346 2026-04-01
LUTACT
University of California, San Francisco
Phase 1 Recruiting
NCT06325046 2026-03-31
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mayo Clinic
Phase NA Recruiting
NCT02016248 2026-03-30
SBRT Boost for Unfavorable Prostate Cancer'
MemorialCare Health System
Phase NA Recruiting
NCT02064673 2026-03-30
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT05398302 2026-03-30
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT05975775 2026-03-30
LORP
GCS Ramsay Santé pour l'Enseignement et la Recherche
Recruiting
NCT06244004 2026-03-30
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Northwestern University
Phase 2 Recruiting
NCT06280781 2026-03-30
IP9-ATLAS
Imperial College London
Phase NA Recruiting
NCT06389097 2026-03-30
(SEEtoTREAT)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting
NCT06672926 2026-03-30
NEWPROMRI
University Hospitals of North Midlands NHS Trust
Recruiting
NCT07500701 2026-03-30
Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
Samsung Medical Center
Phase 3 Recruiting